Jeff Williams

Jeff has more than 20 years of experience leading companies in life sciences and molecular diagnostics. Most recently, Jeff was CEO and Chairman of the Board at NeuMoDx Molecular, leading the company from inception through rapid commercial growth to a sale to QIAGEN in 2020. Additionally, he served as President & CEO of Accuri Cytometers, which was acquired by Becton Dickinson in March 2011 for $205 million. Prior to Accuri, Jeff was President and CEO of HandyLab, Inc., a clinical diagnostic company that was purchased by Becton Dickinson in November 2009 for $275 million. Jeff also served as President and CEO of Genomic Solutions Inc., a company he co-founded in 1997, culminating in an IPO on NASDAQ in 2000 and merger with Harvard Biosciences, Inc. in 2002. He received a BS in Biology from Alma College and an MBA from the Ross School of Business at the University of Michigan.